Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02685995 · ClinicalTrials.gov registry record · NA
VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC
A NA study of Renal Failure Chronic Requiring Hemodialysis and Chronic Renal Insufficiency, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT02685995: Completed NA study of Renal Failure Chronic Requiring Hemodialysis and Chronic Renal Insufficiency, sponsored by University of Pennsylvania.
NCT02685995 is a NA study of Renal Failure Chronic Requiring Hemodialysis and Chronic Renal Insufficiency that has completed, run by University of Pennsylvania. The registered enrollment target is 100 participants, above the 23-participant average among 3 other Renal Failure Chronic Requiring Hemodialysis trials with a reported enrollment target (335% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02685995, a NA study of Renal Failure Chronic Requiring Hemodialysis and Chronic Renal Insufficiency, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Randomized two-arm study examining 90 day primary patency of two FDA-approved tunneled dialysis catheters.
Primary Outcome
The primary study endpoint will be primary patency at 90 days following catheter insertion. Primary patency is defined as an HD catheter which provides adequate hemodialysis (flow \>300mL/min) without need for additional interventions (ie TPA infusions or catheter exchange) to maintain flow or correct device failure.
Conditions Studied
Interventions
- DEVICE VectorFlow TDC
- DEVICE Palindrome TDC
Study Locations (2)
Pennsylvania
- Hospital of the Unviersity of Pennsylvania - Philadelphia
- Penn Presbyterian Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-07 |
| Phase | NA |
What the finished NCT02685995 record still lists
NCT02685995 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 23-participant average among 3 other Renal Failure Chronic Requiring Hemodialysis trials with a reported enrollment target (335% higher).
The record links to 2 conditions, with Renal Failure Chronic Requiring Hemodialysis appearing as the primary indexed condition, and to 2 interventions - of which VectorFlow TDC is the first listed.
NCT02685995 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02685995 about?
NCT02685995 is a clinical study titled "VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC". Randomized two-arm study examining 90 day primary patency of two FDA-approved tunneled dialysis catheters.
What is the current status of trial NCT02685995?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-12. Estimated completion is 2020-07.
What conditions does trial NCT02685995 study?
This clinical trial studies the following conditions: Renal Failure Chronic Requiring Hemodialysis, Chronic Renal Insufficiency.
What interventions are being tested in trial NCT02685995?
The interventions under investigation include: VectorFlow TDC (DEVICE), Palindrome TDC (DEVICE).
Who is sponsoring clinical trial NCT02685995?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02685995 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Failure Chronic Requiring Hemodialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia